Jacobson Pharma Corporation Limited (2633.HK)
2633.HK Stock Price Chart
Explore Jacobson Pharma Corporation Limited interactive price chart. Choose custom timeframes to analyze 2633.HK price movements and trends.
2633.HK Company Profile
Discover essential business fundamentals and corporate details for Jacobson Pharma Corporation Limited (2633.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
21 Sept 2016
Employees
1.73K
Website
https://www.jacobsonpharma.comCEO
Kwong Yip Sum
Description
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
2633.HK Financial Timeline
Browse a chronological timeline of Jacobson Pharma Corporation Limited corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 11 Aug 2025
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 28 Aug 2025.
Dividend declared on 25 Feb 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 2 Apr 2025.
Earnings released on 21 Nov 2024
EPS came in at $0.07 , while revenue for the quarter reached $810.00M .
Dividend declared on 3 Sept 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 4 Oct 2024.
Earnings released on 12 Jul 2024
EPS came in at $0.06 , while revenue for the quarter reached $752.88M .
Dividend declared on 18 Dec 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 10 Jan 2024.
Earnings released on 30 Sept 2023
EPS came in at $0.07 , while revenue for the quarter reached $714.92M .
Dividend declared on 15 Aug 2023
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 1 Sept 2023.
Earnings released on 15 Jun 2023
EPS came in at $0.06 , while revenue for the quarter reached $968.23M .
Dividend declared on 8 Dec 2022
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 29 Dec 2022.
Dividend declared on 3 Oct 2022
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 18 Oct 2022.
Earnings released on 30 Sept 2022
EPS came in at $0.07 , while revenue for the quarter reached $817.35M .
Earnings released on 31 Mar 2022
EPS came in at $0.05 , while revenue for the quarter reached $845.13M .
Dividend declared on 9 Dec 2021
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 23 Dec 2021.
Dividend declared on 5 Oct 2021
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 19 Oct 2021.
Earnings released on 30 Sept 2021
EPS came in at $0.04 , while revenue for the quarter reached $750.41M .
Earnings released on 31 Mar 2021
EPS came in at $0.04 , while revenue for the quarter reached $750.49M .
Dividend declared on 17 Dec 2020
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 6 Jan 2021.
Earnings released on 30 Sept 2020
EPS came in at $0.05 , while revenue for the quarter reached $695.43M .
Dividend declared on 25 Sept 2020
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 Oct 2020.
2633.HK Stock Performance
Access detailed 2633.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.